SIGACHI INDUSTRIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.1 INR | +1.30% |
|
-2.87% | +28.60% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 2.5B 29.99M | Sales 2023 | 3.02B 36.2M | Capitalization | 6.86B 82.25M |
|---|---|---|---|---|---|
| Net income 2022 | 400M 4.79M | Net income 2023 | 435M 5.21M | EV / Sales 2022 | 3.41 x |
| Net cash position 2022 | 345M 4.13M | Net Debt 2023 | 357M 4.28M | EV / Sales 2023 | 2.39 x |
| P/E ratio 2022 |
18.7
x | P/E ratio 2023 |
15.8
x | Employees | 1,089 |
| Yield 2022 * |
-
| Yield 2023 |
0.9% | Free-Float | 41.26% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.30% | ||
| 1 week | -2.87% | ||
| Current month | -1.78% | ||
| 1 month | -5.50% | ||
| 3 months | -15.15% | ||
| 6 months | +59.28% | ||
| Current year | +28.60% |
1 week
63.15
68.70
1 month
60.0070.90
Current year
51.6595.90
1 year
23.0195.90
3 years
21.9895.90
5 years
21.9895.90
10 years
21.9895.90
| Managers | Title | Age | Since |
|---|---|---|---|
Amit Raj Sinha
CEO | Chief Executive Officer | 50 | 06-04-23 |
| Director of Finance/CFO | 52 | 19-03-29 | |
Shreya Mitra
CMP | Compliance Officer | 31 | 19-10-07 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 89-01-10 | |
| Director/Board Member | 81 | 89-01-10 | |
Amit Raj Sinha
CEO | Chief Executive Officer | 50 | 06-04-23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-06 | 66.1 | +1.30% | 1,027,724 |
| 24-05-03 | 65.25 | -1.88% | 867,882 |
| 24-05-02 | 66.5 | -1.19% | 1,035,240 |
| 24-04-30 | 67.3 | -1.10% | 658,146 |
Delayed Quote NSE India S.E., May 06, 2024 at 07:43 am EDT
More quotes
Sigachi Industries Limited is an India-based company that manufactures primarily microcrystalline cellulose (MCC). The Company is engaged in manufacturing cellulose-based excipients for finished dosages in the pharmaceutical industry. The Companyâs products include EXCiPACT GMP, SGMP, HACCP and EDQM CEP. The Company's pre-formulated excipients include BARETab PH, BARETab ODT and BARETab Nutra. It produces MCC in various grades ranging from 15 to 250 microns for the domestic and export markets under the HiCel and AceCel brands. The Company offers Anti-ulcers (Gastrointestinal) Products and their Intermediates. It operates over three manufacturing units situated in Hyderabad, Jhagadia and Dahej. The Company serves pharmaceutical, food and nutraceuticals, cosmetic and chemical industries. Its international business spreads across 50 countries, including Asia, Australia, American Continent, Europe and the Middle East.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +28.60% | 253M | |
| +31.52% | 662B | |
| +21.96% | 546B | |
| -5.21% | 359B | |
| +17.02% | 323B | |
| +5.01% | 289B | |
| +13.68% | 234B | |
| +3.81% | 198B | |
| -10.63% | 194B | |
| +3.98% | 167B |
- Stock Market
- Equities
- SIGACHI Stock